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Background: Obesity is a worldwide metabolic disorder affecting all types of people. The mechanism by which
increased body fat mass that leads to insulin resistance and type 2 diabetes is not yet clearly known. There is a
possible crosstalk between leptin, an adipokine and insulin signaling. Leptin mediates insulin sensitivity in
hepatocytes; however, its concentration has found to be increased in obese and diabetic subjects. These subjects
also have high incidence of oxidative stress status. Therefore, knowing the level of leptin present in obese diabetic
subjects will be informative along with its relation to oxidative stress.
Methods: A small population study was performed to explore the association between leptin concentration and
oxidative stress status in control and obese type 2 diabetic subjects. Oxidative stress status parameters like
malondialdehyde (MDA), superoxide dismutase activity (SOD), glutathione peroxidase activity (GSH-Px), and protein
carbonyl (PCO) groups content was measured spectrophotometrically in serum of 43 subjects. Serum Leptin
concentration was measured by quantikine sandwich ELISA assay.
Results: The strong positive correlation between MDA (malondialdehyde) and leptin in obese diabetic patients
(ρ = 0.787, P < 0.05) suggests close association between lipid peroxidation and hyperleptinemia. In addition,
observed positive correlation between protein carbonyl groups and leptin level in obese diabetic subjects
(ρ = 0.599, P = 0.001) suggest that hyperleptinemia might also be associated with increased protein oxidation. In
multiple logistic regression analysis, leptin has shown a significant association with obese type 2 diabetes [odds
ratio (OR): 1.161, 95% confidence interval (Cl): 1.027-1.312, P < 0.05], but the significance is lost after adjusting for
Age, BMI, MDA and anti-oxidant parameters.
Conclusions: In the subjects with both obesity and diabetes, there is a significant degree of association
between hyperleptinemia and oxidative stress. This association reinforces the existing understanding that obese
subjects who also have diabetes are vulnerable to cardiovascular complications driven by increased oxidative
stress and hyperleptinemia.
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Obesity and diabetes, together called as diabesity, is
the ever growing metabolic disorder of industrialized
and developing countries. At present, India stands next
to China with 63 million diabetic population [1]. The
mechanism linking insulin resistance, oxidative stress,
adipokines in type 2 diabetes and obese subjects is
poorly understood. There is strong evidence that adi-
pocytes play a critical role in metabolism through the
secretion of hormones and cytokines that alter whole-
body energy homeostasis [2]. Leptin, 16-kDa protein
secreted by adipocytes was first identified as the prod-
uct of a gene designated ob (obese) in laboratory mice
[3,4]. In adipocytes, leptin inhibits glucose uptake, im-
pairs lipogenesis, glycogen synthase and inhibits lipoly-
sis [5]. In hepatocytes, leptin triggers insulin-like
effects through regulating insulin-signaling pathway
[6]. Hence, there is a possible cross talk between leptin
and insulin signaling, making hepatocytes more sensi-
tive to insulin. Interestingly, presence of higher leptin
levels especially in obese subjects makes them even
more resistance to insulin-like effects thus mediating
type 2 diabetes in obese subjects. This has been well
confirmed in studies showing rise in circulating leptin
levels in relation to BMI and percentage total body fat
[7,8]. Leptin levels were found to be either same or
lower in subjects with diabetes but significantly higher
in obese and obese diabetic condition [9,10]. Being an
adipokine, leptin levels rise with increasing BMI and
body fat, but its relation with diabetes and insulin re-
sistance seems to be intriguing, as individuals who
have both obesity and type 2 diabetes exhibit higher
leptin levels when compared to obese or diabetic popu-
lation alone. The mechanism linking this behavior may
be contributed in part to oxidative stress. Hyperlepti-
nemia and oxidative stress are the consequences of
obesity [11], and may play a role in mediating T2DM
in obesity. Studies have shown leptin as a possible me-
diator of oxidative stress in obese and obese diabetic
subjects. Leptin has been shown to correlate strongly
with MDA (product of lipid peroxidation) levels in
T2DM subjects [10]. Leptin also increases the reactive
oxygen species (ROS) in endothelial cells [12]. In fact
endothelial dysfunction is one mechanism which can
disturb glucose homeostasis via increased oxidative
stress [13]. Oxidative stress plays a critical role in the
development of type 2 diabetes and associated cardio-
vascular complications [14,15]. Interestingly adminis-
tration of leptin was shown to mitigate the expression
levels of genes related to oxidative stress and inflamma-
tion in the skeletal muscle of ob/ob Mice [16]. Leptin
treatment was also shown to reduce lipid peroxidation
in STZ-diabetic rats through enhancing the GSH levels
[17]. This shows the necessity of leptin in reducing theoxidative stress in muscle tissues and the possible in-
verse oxidative stress inducing effect due to aberrations
in leptin signaling in hyperleptinemia. Also in South In-
dian population, there is lack of data to clearly explain
the relationship between leptin and oxidative stress.
Therefore it is of imperative need to analyze the associ-
ation of hyperleptinemia and oxidative stress in the
population with diabetes and obesity. In the present
study, we have investigated the possible relationship of
leptin with various oxidative stress parameters in obese
diabetic and healthy individuals. The serum leptin levels
are compared with age, Body Mass Index (BMI), Waist
to Hip ratio (WHR), systolic/diastolic blood pressure
(BP), Fasting Blood Glucose (FBG), Malondialdehyde
(MDA), Superoxide dismutase (SOD), Glutathione per-




A total of 43 subjects from Gudiyattam, Tamilnadu,
India were included in the study. Two groups were
selected: control population (n = 17) containing non-
obese, non-diabetic subjects and obese type 2 diabetic
population (n = 26) containing subjects suffering from
both obesity and type 2 diabetes. The criteria for dia-
betes were based upon WHO/IDF reports on definition
and diagnosis of diabetes mellitus [18]. The criteria for
obesity were re-defined according to the WHO guide-
lines which use a BMI of 25 kg/m2 for defining obes-
ity in South Asians [19]. Intra-abdominal obesity was
also assessed by measuring waist-to-hip ratio (WHR)
which existed if WHR ≥ 1.0 for males and ≥ 0.86 for
females [20].
The individuals were asked to reveal their age, gender,
blood pressure and other risk factors including arterial
hypertension, smoking, hyperlipidemia, current medica-
tion and other socioeconomic variables by replying to a
series of standard questionnaire. Patients who had expe-
rienced clinical infection of renal, hepatic or any malig-
nant disease, myocardial infarction, surgery or major
trauma were excluded from the study.
The study was carried out according to the ethical stan-
dards of Palar hospital, Gudiyattam and VIT University,
Vellore. Written informed consent was obtained from all
the individuals participated in the study.
Sample collection and analysis
Venous blood (5 ml) was collected from each individual
after over-night fasting (>10 hr). Serum was then ob-
tained, aliquoted and stored at −20°C for further ana-
lysis. Glucometer (One touch Horizon™) was used to
analyze fasting blood glucose levels. Serum leptin levels
were estimated using Leptin ELISA Kit following the
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Lipid peroxidation was measured by estimating serum
malondialdehyde (MDA) levels-a thiobarbituric acid re-
active substance formed as a byproduct of lipid peroxi-
dation [21].
The assay of Superoxide dismutase (SOD) activity
was done by using the procedure of Kakkar et al. [22].
The assay was measured in terms of inhibition of
Nitroblue tetrazolium (NBT) reduction by Superoxide
dismutase enzyme present in the serum.
Glutathione Peroxidase (GPx) activity was deter-
mined as reported by Rotruck et al. [23]. The proced-
ure is based upon a reaction in which the leftover
glutathione (GS-SG) present in the serum (after gluta-
thione peroxidase converts monomeric glutathione to
glutathione disulphide) reacts with the DTNB (5,5′-
dithiobis 2-nitrobenzoic acid) to form a compound
which absorbs at 412 nm. The Protein Carbonyl (PCO)
group was used as a marker of severe protein oxida-
tion. It involves the derivatization of the carbonyl
group with 2,4-dinitrophenylhydrazine (DNPH), which
leads to the formation of the stable dinitrophenyl
hydrazone product [24].Statistical analysis
The results were expressed as mean ± S.D. Two-tailed
Student’s t-test is employed to determine the signifi-
cance of the data. Pearson correlation was used to
examine the strength of correlation between various risk
factors and Leptin levels. Multiple logistic regression
analysis was performed using leptin as independent
variable and type 2 diabetes and obesity as dependent
variable after adjusting for Age, BMI, and oxidative
stress parameters. The values were considered as statis-
tically significant if p < 0.05.Table 1 Clinical, oxidative stress status, and leptin levels of th
Parameter Control (non-obese, non-diabe
Total subjects n = 17
Age (years) 41.2 ± 10.1
BMI (kg/m2) 23.40 ± 2.6
WHR 0.975 ± 0.09
Systolic blood pressure (mm/hg) 144.4 ± 23.5
Diastolic blood pressure (mm/hg) 98.4 ± 17.7
FBG (mg/dl) 95.4 ± 12.0
Leptin (ng/ml) 12.03 ± 7.4
MDA (μM) 1.50 ± 0.51
SOD activity (U/ml) 2.99 ± 0.98
GSH Px Activity (U/ml) 0.173 ± 0.01
Protein carbonyls’ content (μM/Litre) 8.99 ± 0.06
Data are expressed as mean ± SD, p < 0.05 is considered as statistically significant foResults
Anthropometric measures, clinical and oxidative stress
parameters, and leptin concentration of the two popula-
tions are presented in Table 1. The level of leptin and
MDA is significantly high in obese diabetic population
compared to control subjects. Antioxidant defense sta-
tus as indicated by SOD and GPx activity also decreases
in obese diabetic population with SOD showing signifi-
cant reduction. Protein oxidation as represented by
PCO has shown a significant rise in obese diabetic
population as compared to control population.
To analyze the influence of oxidative stress parame-
ters on leptin levels, Pearson correlation is performed
(Table 2). The strong correlation between BMI and leptin
levels in both the population (control: r = 0.646, P < 0.01;
obese diabetic: r = 0.806; P < 0.001) has clearly shown the
effects of BMI on leptin concentration. There is a signifi-
cant strong correlation exist between MDA and leptin
levels in obese diabetic population (r = 0.787, P = <0.001).
Antioxidant defense status (SOD and GPx activity) has
shown negative correlation and protein oxidation (PCO
content) has shown positive correlation with leptin levels
in obese diabetic subjects.
In multiple logistic regression model (Table 3), leptin
has shown a significant association with obese type 2
diabetes [odds ratio (OR): 1.161, 95% confidence inter-
val (Cl): 1.027-1.312, P < 0.05], but the significance is
lost after adjusting for Age, BMI, MDA and anti-oxidant
parameters.
Discussion
This study aims to explore the possible association of
leptin with oxidative stress status in normal and obese
type 2 diabetic population. It has clearly presented the
following case: Leptin is positively correlated with BMI
in both the population. Leptin is positively correlatede study groups
tic) population Obese type 2 diabetic population P-value
n = 26
55.55 ± 8.15 0.191
28.57 ± 3.06 0.0002
1.09 ± .07 0.004
153.7 ± 28.7 0.955
88.4 ± 12.69 0.373
171.23 ± 41.46 0.008
26.85 ± 13.11 0.003
1.99 ± 0.7 0.003
1.92 ± 1.19 0.001
0.16 ± 0.02 0.818
10.71 ± 3.9 0.0007
r all the groups compared to control.
Table 2 Correlation between leptin concentrations and the parameters of oxidative stress status
Variables Control (non-obese, non-diabetic) population (n = 17) Obese diabetic population (n = 26)
Pearson’s coefficient P Pearson’s coefficient P
Age (years) −0.624 0.053 0.479 0.243
BMI 0.646 0.005 0.806 0.0001
WHR −0.819 0.058 0.450 0.302
FBG (mg/dl) −0.001 0.999 −0.272 0.179
MDA (μM) 0.256 0.322 0.787 0.0001
SOD activity (U/ml) −0.116 0.657 −0.190 0.353
GPx activity (U/ml) 0.010 0.970 −0.690 0.069
nM/mg 0.249 0.335 0.599 0.001
Pearson Correlation coefficient are indicated, p < 0.05 is considered as statistically significant.
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type 2 diabetic population. Leptin is also a strong pre-
dictor of obese type 2 diabetes with BMI, WHR and oxi-
dative stress status.
Leptin is an adipokine known to regulate energy ex-
penditure and keep body fit and healthy [25]. On the
contrary, biologically it is also an active mediator of
type 2 diabetes and so its exact role in the development
of insulin resistance still remains unclear [26]. In our
study, obese diabetic individuals have significantly
higher levels of circulatory leptin. The same group is
also characterized by reduced antioxidative activity, in-
creased lipid peroxidation, and higher protein oxida-
tion as indicated by SOD/GSH-Px, MDA and PCO
levels. This strongly indicates the role of metabolic
stress on circulatory leptin levels.
MDA, a major toxic TBARS (Thiobarbituric acid re-
active substances) product were measured in our vol-
unteers as an index of lipid peroxidation. It has been
shown that hyperleptinemia plays a key role in the for-
mation of lipid peroxides thus mediating oxidative
stress, corroborated by the previous observation that
leptin increased the oxidative stress in tissues where
there is high rate of fatty acid oxidation, including
muscle tissues [27]. In results of correlation analysis
(Table 2) leptin is strongly correlated with MDA in
both the population suggesting an association of lipidTable 3 Multiple logistic regression analysis with obese type
independent variable
Variable Odds ratio (OR)
Leptin-Unadjusted 1.161
Adjusted for Age 1.110
Adjusted for BMI 0.793
Adjusted for MDA 0.326
Adjusted for SOD 0.449
Adjusted for PCO 1.413
Odds ratio values and p values are indicated, p < 0.05 considered as statistically sigperoxidation and leptin. This association is even
greater for obese diabetic individuals indicating that
these people are under severe oxidative stress.
There is a general understanding that BMI is a strong
predictor of obesity. But WHR (Waist to Hip ratio) is
also a useful indicator of intra-abdominal obesity. Our
data, however, confirmed that BMI alone may be a
strong predictor of clinical manifestations of obesity as
a strong and significant correlation exists between lep-
tin and BMI in obese diabetic population.
To evaluate the antioxidant potential of human sub-
jects against the superoxide radical, we have measured
in vitro SOD activity and correlated with serum leptin
levels. The SOD activity is significantly decreased in
obese diabetic condition compared to healthy subjects
(Table 1). This agrees with the earlier report of low SOD
activity in type 2 diabetic patients [28]. Glutathione per-
oxidase has also been assessed for its peroxidase activity
in serum, i.e., to reduce free hydrogen peroxide to water.
Our results have also shown a decrease in the peroxid-
ase activity of the enzyme in obese diabetic subjects
(Table 1). However, we failed to establish a significant
relationship between leptin, SOD and GSH-Px in the
correlation analysis.
Another important marker of oxidative stress is pro-
tein carbonylation measured through estimating protein
carbonyl groups content (PCO) in serum. Measuring2 diabetes as dependent variable and leptin as







nificant for all the groups compared to control.
Pandey et al. Journal of Diabetes & Metabolic Disorders  (2015) 14:24 Page 5 of 6PCO group is advantageous over other biomarkers of
oxidative stress due to their early formation and de-
tectable stability arising from protein side chains (Pro,
Arg, Lys, and Thr). It has been shown that PCO level
increases in diabetic patients as compared to healthy
volunteers [29]. We also observed a significant in-
crease in protein oxidation in the patient group as
compared to normal healthy group (Table 1). In fact,
PCO levels show a strong and significant correlation
with leptin among obese diabetic individuals, making
them vulnerable to the effects of hyperleptinemia.
Thus we have observed a close association between
hyperleptinemia and oxidative stress in obese diabetic
subjects. Previous finding on leptin induced oxidative
stress via increased fatty acid oxidation corroborates
this observation [30]. Obese diabetic subjects are more
vulnerable to cardiovascular complications further
driven by increased oxidative stress and hyperleptine-
mia [31]. It is hard to say without any in vivo model
that whether it is hyperleptinemia which induces oxi-
dative stress in obese subjects and makes them suscep-
tible to insulin resistance or is it oxidative stress which
is causing an abrupt increase in leptin, thus mediating
its harmful effects. Since leptin seems to be more of a
protective hormone [32], we can speculate that may be
oxidative stress induced hyperleptinemia causes an ab-
errant leptin signaling (leptin resistance), thus render-
ing leptin from its protective effects and inducing
insulin resistance in obese people.
Hence, our current study on a small Indian popula-
tion warrants the need for the prospective studies to
understand the association between oxidative stress
and hyperleptinemia.
Conclusions
In the subjects with both obesity and diabetes, there is
a significant degree of association between hyperlepti-
nemia and oxidative stress. This association reinforces
the existing understanding that obese subjects who
also have diabetes are vulnerable to cardiovascular
complications driven by increased oxidative stress and
hyperleptinemia.
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